These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25916760)

  • 1. The REPLACE study in adults and calcilytics.
    Houillier P
    Ann Endocrinol (Paris); 2015 May; 76(2):180-2. PubMed ID: 25916760
    [No Abstract]   [Full Text] [Related]  

  • 2. Mini-review: new therapeutic options in hypoparathyroidism.
    Cusano NE; Rubin MR; Sliney J; Bilezikian JP
    Endocrine; 2012 Jun; 41(3):410-4. PubMed ID: 22311174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
    Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
    Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case series.
    Bislev LS; Sikjaer T; Rejnmark L
    Calcif Tissue Int; 2014 Oct; 95(4):374-81. PubMed ID: 25086672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone therapy for hypoparathyroidism.
    Cusano NE; Rubin MR; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Era for Chronic Management of Hypoparathyroidism: Parathyroid Hormone Peptides.
    Marcucci G; Brandi ML
    Front Horm Res; 2019; 51():165-171. PubMed ID: 30641529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review.
    Angelopoulos NG; Goula A; Tolis G
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):50-4. PubMed ID: 17286236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid gland: Hypoparathyroidism: replacing PTH.
    Greenhill C
    Nat Rev Endocrinol; 2014 Jan; 10(1):3. PubMed ID: 24165998
    [No Abstract]   [Full Text] [Related]  

  • 9. Parathyroid hormone analogues in the therapy of osteoporosis.
    Müller M; Pietschmann P
    Wien Klin Wochenschr; 2008; 120(11-12):321-4. PubMed ID: 18709518
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.
    Marcucci G; Della Pepa G; Brandi ML
    Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant PTH therapy for severe hypoparathyroidism after kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case report.
    Hod T; Riella LV; Chandraker A
    Clin Transplant; 2015 Nov; 29(11):951-7. PubMed ID: 26331695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
    Winer KK; Yanovski JA; Cutler GB
    JAMA; 1996 Aug; 276(8):631-6. PubMed ID: 8773636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism.
    Linglart A; Rothenbuhler A; Gueorgieva I; Lucchini P; Silve C; Bougnères P
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3308-12. PubMed ID: 21865375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
    Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
    Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement.
    Rubin MR; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):220-6. PubMed ID: 20485912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone treatment for osteoporosis.
    Cosman F
    Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):495-501. PubMed ID: 18971677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.
    Mannstadt M; Clarke BL; Vokes T; Brandi ML; Ranganath L; Fraser WD; Lakatos P; Bajnok L; Garceau R; Mosekilde L; Lagast H; Shoback D; Bilezikian JP
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does PTH Replacement Therapy Improve Quality of Life in Patients With Chronic Hypoparathyroidism?
    Winer KK
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2752-2755. PubMed ID: 29897557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of parathyroid hormone in hypoparathyroidism.
    Cusano NE; Rubin MR; Irani D; Sliney J; Bilezikian JP
    J Endocrinol Invest; 2013 Dec; 36(11):1121-7. PubMed ID: 24445125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.